EP2207879A4 - Identification et isolement de cellules et d'acide nucléique f taux - Google Patents

Identification et isolement de cellules et d'acide nucléique f taux

Info

Publication number
EP2207879A4
EP2207879A4 EP08831741A EP08831741A EP2207879A4 EP 2207879 A4 EP2207879 A4 EP 2207879A4 EP 08831741 A EP08831741 A EP 08831741A EP 08831741 A EP08831741 A EP 08831741A EP 2207879 A4 EP2207879 A4 EP 2207879A4
Authority
EP
European Patent Office
Prior art keywords
isolation
identification
nucleic acid
fetal cells
fetal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08831741A
Other languages
German (de)
English (en)
Other versions
EP2207879A2 (fr
Inventor
Farideh Bischoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Biocept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocept Inc filed Critical Biocept Inc
Publication of EP2207879A2 publication Critical patent/EP2207879A2/fr
Publication of EP2207879A4 publication Critical patent/EP2207879A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5302—Apparatus specially adapted for immunological test procedures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP08831741A 2007-09-21 2008-09-22 Identification et isolement de cellules et d'acide nucléique f taux Withdrawn EP2207879A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97439207P 2007-09-21 2007-09-21
PCT/US2008/077251 WO2009039507A2 (fr) 2007-09-21 2008-09-22 Identification et isolement de cellules et d'acide nucléique fœtaux

Publications (2)

Publication Number Publication Date
EP2207879A2 EP2207879A2 (fr) 2010-07-21
EP2207879A4 true EP2207879A4 (fr) 2011-01-26

Family

ID=40468814

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08831741A Withdrawn EP2207879A4 (fr) 2007-09-21 2008-09-22 Identification et isolement de cellules et d'acide nucléique f taux

Country Status (12)

Country Link
EP (1) EP2207879A4 (fr)
JP (1) JP2010539906A (fr)
KR (1) KR20100061539A (fr)
CN (1) CN101883851A (fr)
AU (1) AU2008302040A1 (fr)
BR (1) BRPI0817199A2 (fr)
CA (1) CA2699958A1 (fr)
IL (1) IL204585A0 (fr)
MX (1) MX2010003116A (fr)
NZ (1) NZ584165A (fr)
WO (1) WO2009039507A2 (fr)
ZA (1) ZA201001912B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8476013B2 (en) * 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
US20120100538A1 (en) 2009-03-24 2012-04-26 Biocept, Inc. Devices and methods of cell capture and analysis
AU2010229924B2 (en) 2009-03-24 2016-07-21 Plus Therapeutics Inc. Devices and methods of cell capture and analysis
ES2577017T3 (es) 2009-12-22 2016-07-12 Sequenom, Inc. Procedimientos y kits para identificar la aneuploidia
EP2820129A1 (fr) * 2012-03-02 2015-01-07 Sequenom, Inc. Méthodes et procédés d'évaluation non effractive de variations génétiques
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2876692C (fr) 2012-06-22 2022-05-24 Quantrx Biomedical Corporation Procede d'obtention de cellules foetales et composants cellulaires foetaux
US20140093873A1 (en) 2012-07-13 2014-04-03 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US11060145B2 (en) 2013-03-13 2021-07-13 Sequenom, Inc. Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
EP3736344A1 (fr) 2014-03-13 2020-11-11 Sequenom, Inc. Méthodes et procédés d'évaluation non invasive de variations génétiques
JP6637218B2 (ja) * 2017-03-27 2020-01-29 積水メディカル株式会社 抗体を用いた標的核酸濃縮及び回収法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007121276A2 (fr) * 2006-04-12 2007-10-25 Biocept, Inc. Enrichissement d'adn foetal de circulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09510875A (ja) * 1994-03-29 1997-11-04 ジェンザイム・コーポレイション 母親の末梢血からの胎児細胞の培養および単離
CA2476835A1 (fr) * 2002-02-20 2003-08-28 University Of Virginia Patent Foundation Test diagnostique non invasif mettant en oeuvre des marqueurs de modification de l'histone
GB0211904D0 (en) * 2002-05-23 2002-07-03 Medical Res Council Nuclear transfer
US20050181429A1 (en) * 2003-04-03 2005-08-18 Monaliza Medical Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
US20040197832A1 (en) * 2003-04-03 2004-10-07 Mor Research Applications Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007121276A2 (fr) * 2006-04-12 2007-10-25 Biocept, Inc. Enrichissement d'adn foetal de circulation

Also Published As

Publication number Publication date
EP2207879A2 (fr) 2010-07-21
IL204585A0 (en) 2010-11-30
JP2010539906A (ja) 2010-12-24
WO2009039507A3 (fr) 2009-06-18
CA2699958A1 (fr) 2009-03-26
WO2009039507A2 (fr) 2009-03-26
BRPI0817199A2 (pt) 2014-10-14
NZ584165A (en) 2012-09-28
AU2008302040A1 (en) 2009-03-26
CN101883851A (zh) 2010-11-10
MX2010003116A (es) 2010-08-03
ZA201001912B (en) 2011-05-25
KR20100061539A (ko) 2010-06-07

Similar Documents

Publication Publication Date Title
IL204585A0 (en) Identification and isolation of fetal cells and nucleic acid
GB0814570D0 (en) Isolation of nucleic acid
GB0701253D0 (en) Nucleic acid amplification and testing
IL214034A0 (en) Single -cell nucleic acid analysis
PL2334786T3 (pl) Izolacja i identyfikacja glikozaminoglikanów
EP2229457A4 (fr) Séparation spécifique à chaque sexe de spermatozoïdes et d'embryons
SG2014014617A (en) Nucleic acid analysis
EP2242857A4 (fr) Procédé d'isolement d'acides nucléiques apoptotiques ou f taux sans cellules
EP2310524A4 (fr) Procédés de cartographie d'acides nucléiques et d'identification de variations structurelles fines dans les acides nucléiques
PT3375891T (pt) Métodos e dispositivos para compensação de diafonia espectral em amplificação de ácido nucleico multiplex
GB0910302D0 (en) Nucleic acid amplification
SG10201403841QA (en) Novel nucleic acid prodrugs and methods of use thereof
LT2304054T (lt) Izoterminė nukleorūgšties amplifkacija
EP2115123A4 (fr) Lyse selective de cellules de sperme
ZA201102195B (en) Methods and compositions for isolating nucleic acid
EP2344619A4 (fr) Système d identification de cibles acide nucléique multiple dans un seul échantillon et son utilisation
EP2227540A4 (fr) Dédifférenciation de cellules humaines
GB0812862D0 (en) Nucleic acid amplification
EP2195453A4 (fr) Procédé d'amplification d'un acide nucléique
EP2405001A4 (fr) Complexe d'acide nucléique et composition délivrant des acides nucléiques
GB2452543B (en) Nucleic acid transfer techniques
IT1391252B1 (it) Peocedimento per l'identificazione e l'isolamento di cellule mesenchimali a spiccata capacita' osteorigenerativa
GB0814569D0 (en) Isolation of nucleic acid
GB0814572D0 (en) Isolation of nucleic acid
GB0814539D0 (en) Nucleic acid isolation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100414

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20101230

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/09 20060101AFI20090416BHEP

Ipc: C07K 16/28 20060101ALI20101222BHEP

Ipc: G01N 33/53 20060101ALI20101222BHEP

Ipc: C12Q 1/68 20060101ALI20101222BHEP

Ipc: G01N 33/50 20060101ALI20101222BHEP

Ipc: G01N 33/68 20060101ALI20101222BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1146544

Country of ref document: HK

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NOVARTIS AG

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20140507

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140918

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1146544

Country of ref document: HK